Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States | Science | AAAS
Key committee endorses Pfizer's COVID-19 vaccine, clearing way for FDA
Pfizer-BioNTech COVID Vaccine Is First to Win U.S. Authorization - Scientific American
Pfizer announces COVID-19 vaccine over 90% effective | World Economic Forum
Moderna vs. Pfizer: Is There a "Best" mRNA Vaccine? | The Scientist Magazine®
Pfizer and BioNTech start trials of new Omicron-specific jab - BBC News
CDC, FDA see possible link between Pfizer's bivalent shot and strokes - POLITICO
Labeling confusion led to wasted doses of Pfizer Covid-19 vaccine - STAT
FDA Authorizes 3rd Dose of Pfizer Vaccine for Immunocompromised Kids — Children's Cancer Cause
Pfizer postpones FDA request for Covid vaccine for kids under 5
Pfizer-BioNTech Lead Globally with COVID-19 Vaccine | BioSpace
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR